Ginkgo Bioworks Holdings (DNA) — Financial Flexibility Index
Ginkgo Bioworks Holdings (DNA) has a Financial Flexibility Index of -0.08x as of March 2026. Free cash flow of $-44.50 Million (operating CF $-46.43 Million minus capex $1.93 Million) represents 0% of total liabilities ($589.92 Million). Also explore DNA year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ginkgo Bioworks Holdings Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Ginkgo Bioworks Holdings across 7 annual periods. Check asset allocation strategy of Ginkgo Bioworks Holdings to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Ginkgo Bioworks Holdings (2019–2025)
Year-by-year free cash flow to debt coverage for Ginkgo Bioworks Holdings. For the full company profile including market capitalisation, see market cap of Ginkgo Bioworks Holdings.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.27x | $-163.39 Million | $-171.06 Million | $611.11 Million | ▲ +31.2% |
| 2024 | -0.39x | $-257.04 Million | $-319.58 Million | $661.39 Million | ▲ +13.3% |
| 2023 | -0.45x | $-254.70 Million | $-295.50 Million | $568.19 Million | ▼ -80.1% |
| 2022 | -0.25x | $-199.93 Million | $-252.20 Million | $803.04 Million | ▲ +36.5% |
| 2021 | -0.39x | $-197.30 Million | $-253.82 Million | $503.61 Million | ▼ -3.0% |
| 2020 | -0.38x | $-78.01 Million | $-135.83 Million | $205.10 Million | ▼ -231.2% |
| 2019 | -0.11x | $-22.44 Million | $-44.66 Million | $195.47 Million | — |